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Abstract
Backround-IgG antibodies from moth-
ers adequately treated for syphilis can
cross the placenta and appear in the sera
of healthy newborns without infection. In
such infants, a false diagnosis of congeni-
tal syphilis is often made. We have
designed a retrospective survey to deter-
mine the time of seroreversion of the
serological tests for syphilis (STS) in
uninfected newborns born to mothers
who were adequately treated for syphilis.
Materials and Methods-Fifty two
seropositive, untreated newborns born to
51 mothers treated for syphilis were stud-
ied. The newborns were followed at 1, 3,
6, 9, and 12 months of age until serore-
version was detected. The VDRL test was
followed until 12 months in 12 of the 22
newborns who were positive at birth, the
TPHA in 21 of the 46 newborns, and the
FTA-ABS test in 22 ofthe 48 newborns.
Results-In the first serological tests
done within 1 month after birth, the
VDRL was positive in 22 newborns (42%),
the TPHA in 46 (88%), and FTA-ABS in
48 (92%). The VDRL seroreverted within 6
months after birth in 84%, and within 1
year in 100%. The TPHA test serore-
verted in 95% within 1 year after birth.
The FTA-ABS test seroreverted in 100%
within 1 year after birth.
Conclusions-In most seropositive,
untreated newborns born to treated
mothers the VDRL became negative
within 6 months after birth and the
TPHA and FTA-ABS within 1 year. This
result is consistent with current Centers
for Disease Control (CDC) guidelines.
However, although the CDC guidelines
are adequate in general, we think that
some revision is desirable concerning the
IgM test and combination of the test
results in order to rule out congenital
syphilis in seropositive, nonsymptomatic
newborns born to the treated mothers.
(Genitourin Med 1995;71:68-70)
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Introduction
During pregnancy Treponema pallidum can
cross the placenta and cause intrauterine
infection of the fetus. On the basis of the data
reported previously, almost half of the infants
born to mothers with active syphilis develop
the disease, one quarter die in utero, and
another quarter are not infected.' Treatment
of the syphilitic mothers with penicillin is very
effective, preventing prenatal syphilis in 95 to
98% of the infants.2 S
IgG antibodies of adequately treated moth-
ers can cross the placenta and appear in the
sera of healthy newborns without infection. In
such infants, a false diagnosis of congenital
syphilis is often made and, owing to the lim-
ited availability of the 19S(IgM)-FTA test,6 its
confirmation is difficult. According to the
guidelines by the Centers for Disease Control
(CDC),7 if nontreponemal antibodies do not
disappear by the sixth month of age, the infant
should be treated for congenital syphilis.
Additionally, if treponemal antibodies do per-
sist beyond the first year of life, the child
should also be treated.
Although these guidelines are broadly
accepted at present, the supporting data seem
to be few. We have designed this retrospective
survey to determine the time of seroreversion
of the STS in the uninfected newborns born
to the treated mothers.
Materials and methods
In Yonsei Medical Centre, Seoul, Korea, the
venereal disease research laboratory (VDRL)
test is performed on maternal sera at the first
prenatal visit, during the third trimester, and
at delivery. The VDRL test is titred and fluo-
rescent treponemal antibody-absorption
(FTA-ABS) test is performed on all VDRL-
reactive sera. The serology is considered posi-
tive if both the VDRL and FTA-ABS tests are
reactive. In addition, the Treponema pallidum
haemagglutination assay (TPHA) and
19S(IgM)-FTA test are performed on all
seropositive sera. All mothers who are diag-
nosed as having syphilis are treated with peni-
cillin irrespective of the stage of pregnancy
unless the patient is allergic to penicillin.
The VDRL, rapid plasma reagin (RPR),
FTA-ABS, TPHA, and 19S(IgM)-FTA tests
are performed on all the sera of neonates at 5
to 7 days of age whose mother was treated for
syphilis.
In this study, mother-newborn pairs were
identified by reviewing the charts of all the
mothers treated for syphilis before delivery
from January 1982 to November 1992. Forty
nine mothers were considered treated as they
had received penicillin at least 1 month before
delivery. Two cases who had received tetracy-
cline before pregnancy due to penicillin-
allergy were also considered treated.
The newborns' charts were reviewed to
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ratory tests indicated that congenital syphilis
was present at birth. The newborns diagnosed
as having congenital syphilis were excluded
from this study. The diagnosis of congenital
syphilis was based on the guidelines estab-
lished by the CDC.7
Finally, 52 seropositive, untreated new-
borns born to 51 treated mothers were identi-
fied. The newborns were followed at 1, 3, 6,
9, and 12 months of age until seroreversion
was detected. We were able to follow the
VDRL until 12 months only in 12 of the 22
newborns who were positive at birth, the
TPHA in 21 of the 46 newborns, and the







Figure 1 The number of infants with positive VDRL, TPHA, or FTA-ABS tes
1 month after birth among total 52 infants.
Results
Treated mothers
48 Of the 51 mothers who were included in this
study, 49 mothers were treated with penicillin
and the remaining 2 with tetracycline before
pregnancy due to penicillin allergy. The
syphilitic mothers in this study were treated
with benzathine penicillin G, doses ranging
from 2-4 million to 7.2 million units, as rec-
ommended by the CDC.7 There were two
mothers with primary syphilis, four with sec-
ondary syphilis, eight with early latent
syphilis, eight with late latent syphilis, one
50 with congenital syphilis, and 28 with indeter-
minate syphilis. Ten mothers received the
.twithin treatment before pregnancy, 14 in the first


















Figure 2 The number of seroreversions of the VDRL test during 12 months after b
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Of the newborns born to the treated mothers,
52 were considered to be uninfected. Only
one newborn who was excluded from our
study was diagnosed as having congenital
syphilis. This newborn had a 19S(IgM)-FTA
test even though there were no clinical symp-
toms or signs.
In the first serological tests done within 1
month after birth the VDRL was positive in
22 newborns (42%) the TPHA in 46 (88%),
and the FTA-ABS in 48 (92%) (fig 1).
Infants followed up until 12 months of age
Of the 12 infants followed with a VDRL, 5
15 (42%) became seronegative at 3 months of
age, 5 (42%) at 6 months, 1 (8%) at 9
months, and 1 (8%) at 12 months, (fig 2).
dirth Therefore, the VDRL became seronegative
within 6 months after birth in 84%, and
within 1 year in 100%.
Of the 21 infants followed with a TPHA
test, 1 infant (5%) became negative at 3
months of age, 11 (52%) at 6 months, 4
(19%) at 9 months, 4 (19%) at 12 months,
and only 1 (5%) remained positive until 12
months (fig 3). Therefore, the TPHA test
became negative in 95% within 1 year.
Of the 22 infants followed with an FTA-
ABS test, 1 (5%) became negative at 3
months, 13 (59%) at 6 months, 4 (18%) at 9
months, and 4 (18%) at 12 months of age
(fig 4). Therefore, the FTA-ABS test became
negative in all the infants within 1 year.
Discussion
The treatment of choice for syphilis in preg-
15 nancy is penicillin as it readily crosses the pla-
centa and successfully treats the fetus as well
as the mother. The treatment is very effective,































Figure 3 The number of seroreversions of the TPI-A test during 12 months after bi










Figure 4 The number of seroreversions of the FTA-ABS test during 12 month
among the 22 infants followed by the FTA-ABS test.
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